Link Details
- Metabolite
- HMDB0000742 (Homocysteine)
- DrugBank ID
- DB01393
- Drug Name
- Bezafibrate
- Effect
- Increase
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- McCullough PA, Ahmed AB, Zughaib MT, Glanz ED, Di Loreto MJ: Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. Rev Cardiovasc Med. 2011;12(4):173-85. doi: 10.3909/ricm0619. [PubMed:22249508 ]
- MacCallum PK, Cooper JA, Rumley A, Lowe GD, Meade TW: Effect of bezafibrate on plasma homocysteine concentration in men with lower extremity arterial disease. J Thromb Haemost. 2004 Feb;2(2):364-5. [PubMed:14996019 ]
- Dierkes J, Westphal S, Luley C: The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels. Expert Opin Drug Saf. 2004 Mar;3(2):101-11. [PubMed:15006716 ]
- Dierkes J, Westphal S, Luley C: Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet. 1999 Jul 17;354(9174):219-20. [PubMed:10421307 ]
- Lever M, George PM, Slow S, Elmslie JL, Scott RS, Richards AM, Fink JN, Chambers ST: Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. Cardiovasc Drugs Ther. 2009 Oct;23(5):395-401. doi: 10.1007/s10557-009-6188-1. [PubMed:19653086 ]
- Dierkes J, Luley C, Westphal S: Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. Vasc Health Risk Manag. 2007;3(1):99-108. [PubMed:17583180 ]